Net proceeds after underwriting fees will be ~$108M*.
I still think RVNC's 2024 guidance of >=$280M product is a lowball figure that RVNC knows it can beat handily, but based on today's offering the upside to this figure is probably less than what I originally expected.
Will RVNC now decline the third $100M tranche of the Athyrium Capital loan, which has a 3/31/24 deadline for to take the loan? We’ll know soon.
*Assuming exercise of underwriter’s option.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.